Two key lipoprotein nanoparticles, high density lipoproteins (HDL) and low density lipoproteins (LDL), are associated with cardiovascular diseases (CVD). HDL is smallest lipoprotein (~10nm) and considered as good cholesterol where as LDL (20-27nm) is considered as bad cholesterol. PDF
In 2016 nanotechnology was proclaimed yet again as a "revolution" for science and industry. Costs and benefits of applying this novel technology have been debated in detail throughout the past decade before many legislatures. Ethical and social implications of those costs and benefits have reached the level of debate the Parliamentary Assembly of the Council PDF
There has been an increasing amount of interest in the design and preparation of new biomaterials that can be used in the fabrication of medical devices for artificial prostheses or implant applications. The remarkable properties of graphene provide essentially infinite possibilities for various applications. One such area is the biomedical applications PDF
Theranostics is a new promising medical paradigm that synergistically utilise therapeutic and diagnostic capabilities of agents for diagnosis, drug delivery or therapy and therapy response recording. This field is further evolving fast into the nanotheranostic field which is immensely benefitted by multifunctional PDF
Nano particles play a major role in research and high-end applications including composite [1–4], functional surfaces [5,6], analysis [7,8] and new materials [9]. However, controlling the nanoparticles is critical since nanoparticles itself could a significant health concern. Many patented efforts have been contributed looking approaches to developing a new material to control the particles including nanoparticle. PDF